Base · 42 · Uncommon · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium16 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $250 $150–$400 | 51.7× | 829 | 0 |
| ▶PSA 9 | $54.50 $19.50–$65.99 from sold comps | 11.3× | 1,905 | 829 |
| ▶PSA 8.5 | $40.00 | 8.3× | 12 | 2,734 |
| ▶PSA 8 | $38.50 $11.50–$44.99 from sold comps | 8.0× | 1,348 | 2,746 |
| ▶PSA 7 | $41.28 | 8.5× | 699 | 4,094 |
| ▶PSA 6 | $24.20 | 5.0× | 420 | 4,793 |
| ▶PSA 5 | $31.09 | 6.4× | 269 | 5,213 |
| ▶PSA 4 | $34.64 | 7.2× | 108 | 5,482 |
| ▶PSA 3 | $18.31 | 3.8× | 38 | 5,590 |
| ▶PSA 2 | $14.09 | 2.9× | 24 | 5,628 |
| ▶PSA 1 | $27.00 | 5.6× | 11 | 5,652 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9.5 | $52.44 | 10.8× | — | — |
| ▶BGS 9 | $47.68 | 9.9× | — | — |
| ▶BGS 8.5 | $38.99 | 8.1× | — | — |
| ▶BGS 7 | $22.00 | 4.5× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $65.15 | 13.5× | — | — |
| ▶CGC 9.5 | $47.00 unverified | 9.7× | — | — |
| ▶CGC 9 | $45.39 unverified | 9.4× | — | — |
| ▶CGC 8.5 | $17.44 unverified | 3.6× | — | — |
| ▶CGC 8 | $20.36 unverified | 4.2× | — | — |
| ▶CGC 7.5 | $23.16 unverified | 4.8× | — | — |
| ▶CGC 7 | $22.64 unverified | 4.7× | — | — |
| ▶CGC 6.5 | $8.45 unverified | 1.7× | — | — |
| ▶CGC 6 | $10.16 unverified | 2.1× | — | — |
| ▶CGC 5.5 | $16.24 unverified | 3.4× | — | — |
| ▶CGC 5 | $5.00 unverified | 1.0× | — | — |
| ▶CGC 4.5 | $6.13 unverified | 1.3× | — | — |
| ▶CGC 4 | $6.78 unverified | 1.4× | — | — |
| ▶CGC 1 | $235 unverified | 48.6× | — | — |
A model's opinion, not investment advice.